Steven Cohen’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Steven Cohen's CTMX Position: Q3 2026 in Review
Steven Cohen increased its CytomX Therapeutics (CTMX) stake by 10% in Q3 2026, buying an estimated $2.65M and bringing the position to 8,604,802 shares worth $23.4M. The position accounts for 0.03% of the portfolio, ranked #825.
Steven Cohen first reported a position in CTMX in Q2 2018 and has held it in 23 quarters since. The position peaked at $49M in Q1 2021. 193 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Steven Cohen held 8,604,802 shares of CytomX Therapeutics worth $23.4M as of Q3 2026.
- Steven Cohen bought 793,769 CytomX Therapeutics shares in Q3 2026, an estimated $2.65M.
- CytomX Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #825 holding.
- Steven Cohen first reported a position in CytomX Therapeutics in Q2 2018 and has held it in 23 quarters since.
- Steven Cohen's CytomX Therapeutics position peaked at $49M in Q1 2021.
- 193 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.